Literature DB >> 1505029

Autoregulation of the yeast lysyl-tRNA synthetase gene GCD5/KRS1 by translational and transcriptional control mechanisms.

S Lanker1, J L Bushman, A G Hinnebusch, H Trachsel, P P Mueller.   

Abstract

We cloned the GCD5 gene of S. cerevisiae and found it to be identical to KRS1, which encodes lysyl-tRNA synthetase (LysRS). The mutation gcd5-1 changes a conserved residue in the putative lysine-binding domain of LysRS. This leads to a defect in lysine binding and, consequently, to reduced charging of tRNA(Lys). Mutant gcd5-1 cells compensate for the defect in LysRS by increasing GCN4 expression at the translational level. GCN4 protein in turn stimulates transcription of GCD5, leading to increased LysRS activity. We propose an autoregulatory model in which uncharged tRNA(Lys) stimulates the protein kinase GCN2, a translational activator of GCN4, and thereby increases transcription of GCD5 and other genes regulated by GCN4.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1505029     DOI: 10.1016/0092-8674(92)90433-d

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  18 in total

1.  Defects in tRNA processing and nuclear export induce GCN4 translation independently of phosphorylation of the alpha subunit of eukaryotic translation initiation factor 2.

Authors:  H Qiu; C Hu; J Anderson; G R Björk; S Sarkar; A K Hopper; A G Hinnebusch
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

2.  Dimerization by translation initiation factor 2 kinase GCN2 is mediated by interactions in the C-terminal ribosome-binding region and the protein kinase domain.

Authors:  H Qiu; M T Garcia-Barrio; A G Hinnebusch
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

3.  The molecular aetiology of tRNA synthetase depletion: induction of a GCN4 amino acid starvation response despite homeostatic maintenance of charged tRNA levels.

Authors:  Matthew R McFarland; Corina D Keller; Brandon M Childers; Stephen A Adeniyi; Holly Corrigall; Adélaïde Raguin; M Carmen Romano; Ian Stansfield
Journal:  Nucleic Acids Res       Date:  2020-04-06       Impact factor: 16.971

4.  Sequences 5' of the first upstream open reading frame in GCN4 mRNA are required for efficient translational reinitiation.

Authors:  C M Grant; P F Miller; A G Hinnebusch
Journal:  Nucleic Acids Res       Date:  1995-10-11       Impact factor: 16.971

5.  Multicopy tRNA genes functionally suppress mutations in yeast eIF-2 alpha kinase GCN2: evidence for separate pathways coupling GCN4 expression to unchanged tRNA.

Authors:  C R Vazquez de Aldana; R C Wek; P S Segundo; A G Truesdell; A G Hinnebusch
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

6.  Selective control of amino acid metabolism by the GCN2 eIF2 kinase pathway in Saccharomyces cerevisiae.

Authors:  John M Zaborske; Xiaochen Wu; Ronald C Wek; Tao Pan
Journal:  BMC Biochem       Date:  2010-08-04       Impact factor: 4.059

7.  Mutations in the GCD7 subunit of yeast guanine nucleotide exchange factor eIF-2B overcome the inhibitory effects of phosphorylated eIF-2 on translation initiation.

Authors:  C R Vazquez de Aldana; A G Hinnebusch
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

Review 8.  Posttranscriptional control of gene expression in yeast.

Authors:  J E McCarthy
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

9.  Guanine nucleotide exchange factor for eukaryotic translation initiation factor 2 in Saccharomyces cerevisiae: interactions between the essential subunits GCD2, GCD6, and GCD7 and the regulatory subunit GCN3.

Authors:  J L Bushman; M Foiani; A M Cigan; C J Paddon; A G Hinnebusch
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

10.  Ability of wild-type and mutant lysyl-tRNA synthetase to facilitate tRNA(Lys) incorporation into human immunodeficiency virus type 1.

Authors:  Shan Cen; Hassan Javanbakht; Meijuan Niu; Lawrence Kleiman
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.